Efficacy and tolerability of diet rich in flaxseed in coronary artery disease patients

Efficacy and tolerability of diet rich in flaxseed in coronary artery disease patients- A randomized single blind trial - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/09/057275

Enrollment

100

Registered

2023-09-06

Start date

Unknown

Completion date

Unknown

Last updated

2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I252- Old myocardial infarction

Interventions

Intervention1: Flaxseeds: patients will receive 30 grams of milled flaxseed once a day with meal. Control Intervention1: No change in dietary habits.: patients will have a normal routine diet.

Eligibility

Inclusion criteria

Inclusion criteria: All patients with angiographically confirmed coronary artery disease.

Exclusion criteria

Exclusion criteria: allergy to flaxseeds

Design outcomes

Primary

Measure	Time frame
incidence of myocardial infarction and strokeTimepoint: baseline, 1 year	—

Secondary

Measure	Time frame
changes in levels of serum lipid & glycosylated haemoglobin.Timepoint: 3 months,6 months & 1 year	—

Countries

India

Contacts

Public ContactNikhil Mudgalkar

Prathima Institue of Medical Sciences

drniks2000@yahoo.com8019615167

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026